Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH |
Lifestar Pharma LLC and Mankind Pharma Ltd. |
1:2018cv01689 |
October 26, 2018 |
US District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on December 17, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 9 STIPULATION and [Proposed] Order to Extend Time for Defendants to Answer, Move or Otherwise Respond to the Complaint re #1 Complaint, by Lifestar Pharma LLC, Mankind Pharma Ltd.. (Orlacchio, Adam) |
Filing 8 NOTICE of Appearance by Adam V. Orlacchio on behalf of Lifestar Pharma LLC, Mankind Pharma Ltd. (Orlacchio, Adam) |
![]() |
Filing 7 DECLARATION of Mailing on Mankind Pharma Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
Filing 6 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. Lifestar Pharma LLC served on 11/19/2018, answer due 12/10/2018. (Blumenfeld, Jack) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01689-CFC, 1:18-cv-01690-CFC (rjb) |
Summons Issued with Magistrate Consent Notice attached as to Lifestar Pharma LLC on 10/29/2018; Mankind Pharma Ltd. on 10/29/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (ceg) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957; 9,949,998. (ceg) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/19/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 2/1/2022. (ceg) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Lifestar Pharma LLC, Mankind Pharma Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2490941.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. (Attachments: #1 Exhibits 1-2, #2 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.